This is the authors' abstract. We don't add key points for this paper.
Obesity has become a pandemic in the Asia-Pacific region, with an alarming rate of increase in the prevalence of obesity. The impact of obesity and its associated comorbidities goes beyond the healthcare system, posing a substantial burden not only on the individual, but also on the society and the economy. In this review, we focus on the latest situation in the Asia-Pacific region, and review the diagnostic criteria of obesity, management strategies and access to treatment in the region. National guidelines on obesity management are available in some countries, reflecting the recognition of the problem of obesity by healthcare professionals and government bodies. Although a range of anti-obesity pharmacotherapies and bariatric surgeries are available, access remains restricted and reimbursement criteria vary in different parts of the Asia-Pacific. Prevention is key, as treatment alone cannot reverse the tide of obesity, and a sustained partnership between the patient and the clinician is necessary to manage the chronic disease of obesity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lui et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: